CoverageForm 410-K10-Q8-K13D13G13F

PFMT · Performant Financial Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Income Statement

Line itemQ2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Revenue$37.80M$33.27M-$31.52M$29.36M$27.33M-$29.96M$25.48M$25.73M
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A----------
Total Operating Expenses$35.16M$33.12M-$33.67M$32.10M$31.25M-$30.61M$29.09M$29.52M
D&A$1.90M$1.45M-$1.90M$1.90M$1.40M-$1.30M$1.20M$1.25M
Operating Income$2.64M$150.0K-($2.15M)($2.74M)($3.92M)-($650.0K)($3.60M)($3.79M)
Interest Expense$276.0K$186.0K-$423.0K$351.0K$186.0K-$423.0K$351.0K$414.0K
Income Tax$360.0K$40.0K-$15.0K$16.0K$16.0K-($407.0K)$21.0K$21.0K
Net Income$2.08M($81.0K)-($2.38M)($3.00M)($4.02M)-($580.0K)($3.97M)($4.22M)
EPS - Basic$0.03$0.00-($0.03)($0.04)($0.05)-($0.01)($0.05)($0.06)
EPS - Diluted$0.03$0.00-($0.03)($0.04)($0.05)-($0.01)($0.05)($0.06)

Balance Sheet

Line itemQ2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Cash & Equivalents$9.08M$9.98M$9.29M$7.78M$10.42M$3.79M$7.25M$17.31M$14.98M$12.34M
Accounts Receivable$17.75M$14.71M$14.16M$17.95M$14.07M$14.28M$17.58M$14.13M$12.79M$15.64M
Inventory----------
Accounts Payable$1.07M$1.35M$482.0K$719.0K$888.0K$2.15M$727.0K$872.0K$1.20M$971.0K
Current Assets$47.49M$41.97M$38.36M$38.33M$38.14M$34.08M$39.78M$41.99M$40.96M$43.75M
Total Assets$110.95M$105.36M$101.77M$101.84M$102.44M$99.24M$99.03M$100.71M$100.59M$103.64M
Current Liabilities$17.98M$16.40M$13.97M$14.37M$14.37M$12.40M$12.38M$12.07M$12.05M$11.48M
Long-term Debt------$0$9.08M$9.58M$10.02M
Total Liabilities$28.72M$27.23M$25.27M$26.61M$26.57M$21.59M$18.32M$22.38M$22.68M$22.58M
Stockholders' Equity$82.24M$78.13M$76.50M$75.24M$75.87M$77.65M$80.71M$78.33M$77.92M$81.06M
Retained Earnings($73.20M)($75.28M)($75.20M)($74.70M)($72.31M)($69.32M)($65.30M)($66.56M)($65.98M)($62.00M)

Cash Flow

Line itemQ2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Operating Cash Flow-$2.90M---$121.0K---($2.15M)
Investing Cash Flow-($1.45M)---($3.65M)---($906.0K)
Financing Cash Flow-($765.0K)---($14.0K)---($7.99M)
CapEx-$1.45M---$3.65M---$909.0K
Free Cash Flow-$1.45M---($3.53M)---($3.06M)

Ratios

MetricQ2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Profitability
Gross margin----------
Operating margin7.0%0.5%--6.8%-9.3%-14.3%--2.2%-14.1%-14.7%
EBITDA margin12.0%4.8%--0.8%-2.9%-9.2%-2.2%-9.4%-9.9%
Net margin5.5%-0.2%--7.6%-10.2%-14.7%--1.9%-15.6%-16.4%
Free cash flow margin-4.4%----12.9%----11.9%
FCF / Net income--17.95---0.88---0.72
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate14.8%---------
Return on assets1.9%-0.1%--2.3%-2.9%-4.0%--0.6%-3.9%-4.1%
Return on equity2.5%-0.1%--3.2%-3.9%-5.2%--0.7%-5.1%-5.2%
Return on invested capital--------0.6%-3.3%-3.3%
Liquidity
Current ratio2.642.562.752.672.652.753.213.483.403.81
Quick ratio2.642.562.752.672.652.753.213.483.403.81
Cash ratio0.500.610.670.540.730.310.591.431.241.07
Leverage
Debt / Equity------0.000.120.120.12
Debt / Assets------0.000.090.100.10
Debt / EBITDA-------13.96--
Interest coverage9.6x0.8x--5.1x-7.8x-21.1x--1.5x-10.3x-9.2x
Equity multiplier1.351.351.331.351.351.281.231.291.291.28
Liabilities / Assets0.260.260.250.260.260.220.190.220.230.22
Efficiency
Asset turnover0.340.32-0.310.290.28-0.300.250.25
Inventory turnover----------
Days sales outstanding171d161d-208d175d191d-172d183d222d
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E----------
P / B----------
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)28.7%21.7%-5.2%15.2%6.2%-10.2%-0.8%-5.0%
Revenue CAGR (3y)13.8%7.1%-3.3%-3.7%-4.5%--6.1%-9.0%-17.5%
Revenue CAGR (5y)2.3%-6.2%--2.6%-3.9%-4.8%-0.1%-6.6%-14.7%
Gross profit growth (YoY)----------
Operating income growth (YoY)----230.6%23.9%-3.5%-71.9%-9.0%-154.8%
Net income growth (YoY)-98.0%--311.0%24.6%4.8%-60.3%-25.4%-152.3%
EPS growth (YoY)----200.0%20.0%16.7%-50.0%-25.0%-200.0%
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)------15.5%---42.9%
FCF CAGR (5y)--25.1%--------
Book value growth (YoY)8.4%0.6%-5.2%-3.9%-2.6%-4.2%-4.5%-6.6%-7.7%-6.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2024-12-31.

Product / service

$241.27M total
Health Care$118.29M · 49.0%
Eligibility Based$61.86M · 25.6%
Claims Based$56.43M · 23.4%
Customer Care And Outsourced Services$4.69M · 1.9%

Peer comparison

Same SIC group: Services-Miscellaneous Business Services

CompanyRevenue (last FY)Net marginROE
DFIN$767.00M4.2%8.5%
ASPS$170.97M0.9%-1.5%
NVEE---
SE$19.63B8.0%12.6%
VEII---

Comparing Performant Financial Corp against the 5 most active filers in the same SIC group.